Abstract: Particle analyzing method and apparatus are provided for measuring the intensity of light scattered from a particle as a function of angle. Particles such as biological cells are contained in a stream for travel along a path which includes a scatter line along which the particles pass successively. A beam of collimated monochromatic radiation is directed onto the flow path, and detector means are provided having a radiation acceptance geometry whose projection intercepts the beam along the scatter line. The projected acceptance geometry includes an aperture image located adjacent the scatter line and having a dimension in the direction of travel of the particles which is substantially less than the length of the scatter line such that the angle of scatter radiation detectable by the detector means varies according to the position of the particle along the scatter line. The output from the detector provides a measure of the scatter light intensity versus angle characteristic of the particle.
Type:
Grant
Filed:
June 5, 1975
Date of Patent:
June 1, 1976
Assignee:
The Board of Trustees of Leland Stanford Junior University
Abstract: A chemical species, present in two oxidation states which differ from one another by one equivalent, is added to pigment materials to serve as a recombination center for alternately capturing electrons and holes produced by the pigment materials when they are subjected to ultraviolet light exposure.
Abstract: The compounds 4-carbethoxy-1,4-diazabicyclo[3.2.1]octane and 4-diethylcarbamyl-1,4-diazabicyclo[3.2.1]octane, said compounds having utility as antifilarial agents.
Abstract: New compounds 4-methyl-1,4-cyclohexadiene-1-carboxaldehyde syn-oxime, 4-methoxymethyl-1,4-cyclohexadiene-1-carboxaldehyde syn-oxime, and 4-(1-methoxyethyl)-1,4-cyclohexadiene-1-carboxaldehyde syn-oxime, as well as the compound 1,4-cyclohexadiene-1-carboxaldehyde syn-oxime, are found to have a high degree of sweetness which is accompanied by very little off-taste. The compounds have good stability even in acid solution. They give no evidence of toxicity and can be employed in foods and beverages as synthetic sweetening ingredients.
Type:
Grant
Filed:
August 25, 1975
Date of Patent:
April 20, 1976
Assignee:
Stanford Research Institute
Inventors:
Edward M. Acton, Michael W. Lerom, Herbert Stone
Abstract: Twelve analogs of diethylcarbamazine as prepared by acylation of 3- and 8-methyl-3,8-diazabicyclo[3.2.1]octane, 2-methyl-2,5-diazabicyclo[2.2.2]octane, and 2-methyl-2,5-diazabicyclo[2.2.1]heptane with diethylcarbamyl chloride, ethyl chloroformate, ethyl isocyanate, and cyclohexanecarbonyl chloride. These compounds are formally derived from diethylcarbamazine in possessing two- or one-carbon bridges over the piperazine ring. The compounds have utility as antifilarial agents and as bronchodilators.
Abstract: Twelve analogs of diethylcarbamazine as prepared by acylation of 3- and 8-methyl-3,8-diazabicyclo[3.2.1]octane, 2-methyl-2,5-diazabicyclo[2.2.2]octane, and 2-methyl-2,5-diazabicyclo [2.2.1]heptane with diethylcarbamyl chloride, ethyl chloroformate, ethyl isocyanate, and cyclohexanecarbonyl chloride. These compounds are formally derived from diethylcarbamazine in possessing two- or one-carbon bridges over the piperazine ring. The compounds have utility as antifilarial agents and as bronchodilators.
Abstract: 19-Norpregna-1,3,5(10)-trien-3-ol and loweralkyl homologs thereof wherein the alkyl group attached in the 17.beta. position contains from 2 to 7 carbon atoms. Said compounds, along with the corresponding known 17.beta.-methyl derivative, are found to have antifertility activity, and particularly postcoital antifertility activity, along with very low estrogenic activity, when administered orally to mammals.
Type:
Grant
Filed:
June 16, 1975
Date of Patent:
March 23, 1976
Assignee:
Stanford Research Institute
Inventors:
David F. Crowe, Richard H. Peters, Masato Tanabe, George Detre
Abstract: New 3-methyl-3-nitrosoureido derivatives of the following amino sugars were prepared as analogs of streptozotocin with the anomeric carbon protected, by nitrosating the methylureas in water with N.sub.2 O.sub.3 : 3-amino-3-deoxy-1,2-O-isopropylidene-.alpha.-D-ribofuranose; methyl 3-amino-3-deoxy-.beta.-D-xylopyranoside; methyl 3-amino-3-deoxy-.alpha.-D-altropyranoside; methyl 3-amino-3-deoxy-.alpha.-D-glucopyranoside; and methyl 3-amino-2,3,6-trideoxy-.alpha.-L-lyxohexopyranoside. Tests against murine leukemia L1210 show that the anticancer activity of streptozotocin not only was retained but was enhanced in most of these derivatives.
Type:
Grant
Filed:
December 12, 1974
Date of Patent:
February 24, 1976
Assignee:
Stanford Research Institute
Inventors:
Allan N. Fujiwara, Edward M. Acton, David W. Henry